Company intelligence / Profile preview

Tricon Pharmaceuticals

Scottsdale, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Tricon Pharmaceuticals was a specialty pharmaceutical company primarily focused on the development and commercialization of generic and niche pharmaceutical products. The company maintained a portfolio that included various therapeutic categories, with a notable emphasis on pain management and anti-infective medications. Based in the United States, Tricon operated as a private entity, managing the regulatory approval and distribution of its product line. While it was active in the late 1990s and early 2000s, the company is no longer a prominent player in the current pharmaceutical landscape and is considered inactive.

Therapeutic areas: NeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Tricon Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tricon Pharmaceuticals.

Explore the full profile